Indiana University Research and Technology Corporation
发明人:
KELLEY, Mark R.,FISHEL, Melissa L.,CARDOSO, Angelo A.
申请号：
ES13761860
公开号：
ES2689665T3
申请日:
2013.03.13
申请国别(地区):
ES
年份:
2018
代理人:
摘要：
A Pharmaceutical composition for use in the treatment of Leukemia is selected from the group consisting of pediatric Acute Lymphoblastic Leukemia (all), All Children, All of t Cells (t-all)Refractory and relapsed all, All, All resistant to glucocorticoids, the composition comprises at least acid (3 - [5 - (dimethoxy 2,3 - 6 - methyl - 1,4 - benzoquinoil)] - 2 - (nonyl - 2-propenoic e3330) or a pharmaceutically acceptable Salt thereof.Una composición farmacéutica para usar en el tratamiento de la leucemia seleccionada del grupo que consiste en leucemia linfoblástica aguda (ALL) pediátrica, ALL infantil, ALL de células T (T-ALL), ALL recidivante, ALL refractaria, y ALL resistente a glucocorticoides, la composición comprende al menos ácido 3-[(5-(2,3-dimetoxi-6- metil 1,4-benzoquinoil)]-2-nonil-2-propenoico (E3330) o una sal farmacéuticamente aceptable de este.
